Drug Profile
Research programme: vasopressin receptor antagonists - Schering-Plough
Alternative Names: SCH 756491Latest Information Update: 17 Nov 2009
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class
- Mechanism of Action Vasopressin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 31 Oct 2006 Preclinical trials in Anxiety disorders in USA (unspecified route)